Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply

Rheumatology (Oxford). 2024 Nov 1;63(11):e312-e314. doi: 10.1093/rheumatology/kead669.

Jule Taubmann^{1

2}, Johannes Knitza^{1

2}, Fabian Müller^{2

3}, Simon Völkl³, Michael Aigner³, Sascha Kretschmann³, Armin Atzinger⁴, Torsten Kuwert⁴, Andreas Mackensen^{2

3}, Georg Schett^{1

2}

¹ Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
² Deutsches Zentrum Immuntherapie, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
³ Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁴ Department of Nuclear Medicine, Friedrich-Alexander-Universität Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.

No abstract available

Grants and funding